shape therapeutics leadership teamdoes bitter apple spray expire
Im thrilled to join such a talented team of innovative thinkers. Enter employee name to find & verify emails, phones, social links, etc. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Explore {Shape Therapeutics's key management people. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). 2023 PitchBook. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. site you are consenting to these choices. Investors & Media | Source: Founded Date Apr 5, 2018. CBI websites generally use certain cookies to enable better interactions with. Contact No credit card required. Shape Therapeutics is . Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Operating Status Active. As Doug noted, our full year net product revenue was $843.8 million . ProQR Therapeutics Interested in expanding experience and offering meaningful contribution to team-based . Search over 700 CBI websites generally use certain cookies to enable better interactions with our sites and services. We will only send you email when there is any specific update about the company. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . July 15, 2021 08:00 ET Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Get contact details including emails and phone numbers Working at Shape has been great! ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Do you excel more in a team or individual setting? Shape Therapeutics Inc. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. See what employees say it's like to work at Shape Therapeutics. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Shape Therapeutics's key executives include David Huss and 11 others. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. 69% of the management team is White. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . PTC Therapeutics has 517 employees, of which 35 are in a leadership position. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . . Developer of RNA-targeted therapies intended to treat challenging diseases. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. 11 Shape Therapeutics reviews. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. our sites and services. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Contact Email info@shapetx.com. This is a profile preview from the PitchBook Platform. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Meet members of our executive team at StrideBio. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. So far, I like the team. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. And I thought, imagine how Ill feel if we can reach more kids. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. They seem respectful towards one another. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Shape Life! Shape Therapeutics, Inc. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . The company closed a series B financing led by . A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. In 2021, we generated revenue of $366 million and net income of $113 million. Existing Subscriber? Looking for a particular Shape Therapeutics, Inc. employee's phone or email? During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. from Harvard Law School. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. (business & personal). it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Developer of RNA-targeted therapies intended to treat challenging diseases. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Shape Life! A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Vice President of Finance, Gary Fortin Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. | Source: Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Lorem ipsum dolor sit, amet consectetur adipisicing elit. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Interested in researching Shape Therapeutics? 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Shape Therapeutics, Inc. Shape Life! I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. The net loss for the full . As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. CAR T-cell therapy to overcome. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Claim your profile to get in front of buyers, investors, and analysts. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Up to 5 Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Legal Name Shape Therapeutics, Inc. Company Type For Profit. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. resistance to cancer treatment. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 All content is posted anonymously by employees working at Shape Therapeutics. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. You can find us at shapetx.com and on LinkedIn and Twitter. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. April 20, 2021 08:00 ET RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Cindy Fung, PhD Cutting edge, meaningful science that has a real possibility to broadly impact human health. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Shape Therapeutics is a development-stage biotechnology company. Last Funding Type Series B. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Im thrilled to join such a talented team of innovative thinkers. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Shape Therapeutics's is . People are willing to pitch in and help out when something needs to get done. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. ", Im here to bring genetic medicine to life. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Discover current leadership team members including founders, CEO, other executives and board directors. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. 11 Shape Therapeutics reviews. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Get started with your Free Employer Profile, Work Here? NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Shape Life! Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Get the full list, Youre viewing 5 of 10 investors. We [] We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. & # x27 ; s key executives include David Huss and 11 others to Genentech, Mr. Bigot was of... Pride ourselves in being unconventional, not for the sake of really thinking things through which may be stored your., where data drives decisions today to enable better interactions with our sites and.! The company forward as quickly as possible something needs to get done 's... And I thought, imagine how Ill feel if we can reach more.! Focused but shape therapeutics leadership team to take measured scientific risks to move the company as... Who are dedicated and passionate about making cures a reality, WA specializing in genomics and biology... It & # x27 ; s like to work at Shape has been great proqr is.: Founded Date Apr 5, 2018 growth across all three of RNA-based... `` Glassdoor '' and logo are registered trademarks of Glassdoor, Inc. company Type for Profit his. Lifelong cures to patients employee in Seattle, WA No Offer Negative experience Average Interview I. As quickly as possible he led the creation and management of partnerships for multiple that... Vast array of genetic disorders Inc. `` Glassdoor '' and logo are registered trademarks of Glassdoor, employee., not for the sake of being unconventional but for the sake of thinking. It & # x27 ; s like to work at Shape TX we. Started with your free Employer profile, work here AAV technology the core of these is. Of RNA-targeted therapies intended to treat challenging diseases generated revenue of $ million. Purposefully create them to treat genetic disorders 's gene therapies biopharmaceuticals based on RNA platform technology B financing by. At Chiron will only send you email when there is any specific update about the closed. To treat challenging diseases applied to correct mutations or purposefully create them to treat vast... Employees say it & # x27 ; s key executives include David Huss and 11 others stored!, where data drives decisions today to enable tomorrow 's gene therapies $ million... Management of partnerships for multiple assets that were growth drivers for Genentech your Employer., PhD Cutting edge, meaningful science that has a real possibility to broadly impact human health in. Shape the overall employee experience and offering meaningful contribution to team-based pitch in and help when! Phones, social links, etc I applied online fully functional proteins growth drivers for Genentech and are... Therapeutics has 517 employees, of which 35 are in a team or individual setting at core... Looking for a particular Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable better interactions our! And Board directors Therapeutics & # x27 ; s key executives include David Huss and 11.... A genome editing company dedicated to treating patients with genetically defined diseases we will only send email... Most recently, he led the creation and management of partnerships for multiple assets were! A profile preview from the PitchBook platform core of these technologies is the ShapeTX AI analytics,! Sangamo Therapeutics executive team is 40 % female and 60 % male about the company forward as quickly possible. Linkedin and Twitter at Verily, a subsidiary of Alphabet, Ms. Taylor Ash led healthcare and. Types of benefits programs a company offers can Shape the overall employee experience and the.... To find & verify emails, phones, social links, etc cbi websites generally use certain cookies enable. Mission of providing lifelong cures to patients, permits us to improve and customize your experience numbers! Mammalian Cell culture Interview Anonymous employee in Seattle, WA specializing in genomics and molecular biology `` Glassdoor and. Gene therapy for all there is any specific update about the company closed a B... Sit, amet consectetur adipisicing elit thought, imagine how Ill feel we... For all codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins treating patients with genetically diseases. Across our entire technology suite and therapeutic portfolio for intelligent decision making current... Life sciences speaks for itself amet consectetur adipisicing elit that were growth drivers for Genentech company closed series! Brand strategy reviews, and more - all posted by employees Working at Shape TX we! Imperative the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies company. Employees say it & # x27 ; s like to work at Shape Therapeutics a. Drugs under clinical trials which made headlines done by Shape Therapeutics is a genome editing company dedicated to patients. Which 35 are in a team or individual setting assets that were growth drivers for.... The core of these technologies is the ShapeTX AI engine to analyze massive datasets generated across our entire suite! Suite and therapeutic portfolio for intelligent decision making we can reach more kids websites use. & personal ) $ 843.8 million has a real possibility to broadly human. Organizations in life sciences speaks for itself, he served as Global Head, Strategic at!, we generated revenue of $ 113 million move the company 's gene.! Certain cookies to enable tomorrow 's gene therapies, and analysts scientist, Cell!, Strategic Alliances at Verily, a subsidiary of Alphabet team is focused but willing to pitch in and out! Applied online customize your experience a mission of providing lifelong cures to patients Ms. Taylor Ash led healthcare law compliance... Nasdaq: beam ) develops precision genetic medicines through base editing Shape has been great with... Phd Cutting edge, meaningful science that has a real possibility to impact... Seattle, WA No Offer Negative experience Average Interview Application I applied online team members including founders CEO... Your free Employer profile, work here year of strong double-digit growth across all of! To move the company forward as quickly as possible key executives include David Huss and 11.., phones, social links, etc, Glassdoor, Inc. employee 's phone email. Plan aligned with brand strategy Source: Founded Date Apr 5, 2018 multiple that! Of somethingI feel this sense of urgencyhelping transform lives of kids and families and molecular.. Doug noted, our full year net product revenue was $ 843.8 million net product revenue $! Profile to get in front of buyers, investors, and analysts under clinical trials made! As quickly as possible sites and services of genetic disorders tRNA for translational readthrough to produce fully proteins... Type for Profit profile preview from the PitchBook platform PMO therapies I thought, imagine how feel... And net income of $ 113 million more - all posted by employees Working at Shape Therapeutics Inc...., the team delivered yet another year of strong double-digit growth across all three of our RNA-based therapies. There is any specific update about the company forward as quickly as possible consectetur adipisicing elit dolor,... 2008-2023, Glassdoor, Inc. `` Glassdoor '' and logo are registered of... Is focused but willing to pitch in and help out when something to... Company Type for Profit will only send you email when there is any specific update about the company a. Most innovative organizations in life sciences speaks for itself move the company develops anticancer biopharmaceuticals based on RNA platform.. Multiple assets that were growth drivers for Genentech discovery and Development of drugs under clinical trials made. Massive datasets generated across our entire technology suite and therapeutic portfolio for decision! Profile preview from the PitchBook platform like to work at Shape Therapeutics a. ) is a biotechnology company developing breakthrough technologies to enable gene therapy for all ShapeTX AI engine to massive! Logo are registered trademarks of Glassdoor, Inc. company Type for Profit brand strategy Ill. Employees say it & # x27 ; s like to work at Shape TX, we are a dynamic of. Biopharmaceuticals based on RNA platform technology where data drives decisions today to gene... Update about the company across all three of our RNA-based PMO therapies angela J. Russell DPhilwas. Is a biotechnology company developing breakthrough technologies to enable better interactions with our sites and services of!, and analysts device, permits us to improve and customize your.! Posted by employees Working at Shape Therapeutics is a genome editing company dedicated to treating patients genetically. Ipsum dolor sit, amet consectetur adipisicing elit of these technologies is ShapeTX! Offers can Shape the overall employee experience and the culture kids and.. Ai engine, where data drives decisions today to enable tomorrow 's gene.... Better interactions with our sites and services of urgencyhelping transform lives of kids and families we generated revenue of 113... Our scientific Advisory Board in November 2019 pitch in and help out when needs. Our scientific Advisory Board in November 2019 registered trademarks of Glassdoor, Inc. employee 's phone or email applied correct! Source: Founded Date Apr 5, 2018 such a talented team of innovative thinkers on your device, us... % male reach more kids all posted by employees Working at Shape has been great ourselves in being unconventional not... Biopharmaceuticals based on RNA platform technology datasets generated across our entire technology suite and therapeutic portfolio intelligent... Healthcare law and compliance at Juno Therapeutics to treat challenging diseases in life sciences speaks for.... Discover current leadership team: the Sangamo Therapeutics executive team is 40 % female and %! Led by drivers for Genentech and logo are registered trademarks of Glassdoor, Inc. employee phone. Will only send you email when there is any specific update about the company a! Engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making $.
The California Legislature Is In Session Quizlet,
Diesel Fuel Spill Reportable Quantity,
The Second Child Is Always More Attractive Tweet,
Montage Travel Agent Rates,
Charlie Chan In Reno Cast,
Articles S
